The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Onco-hematology Molecular Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 qPCR
1.2.3 dPCR
1.2.4 Next-Generation Sequencing
1.2.5 Others
1.3 Market by Application
1.3.1 Global Onco-hematology Molecular Testing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 National Reference Lab / Specialty Lab
1.3.3 University Hospital
1.3.4 Community Hospital
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Onco-hematology Molecular Testing Market Perspective (2018-2029)
2.2 Onco-hematology Molecular Testing Growth Trends by Region
2.2.1 Global Onco-hematology Molecular Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Onco-hematology Molecular Testing Historic Market Size by Region (2018-2023)
2.2.3 Onco-hematology Molecular Testing Forecasted Market Size by Region (2024-2029)
2.3 Onco-hematology Molecular Testing Market Dynamics
2.3.1 Onco-hematology Molecular Testing Industry Trends
2.3.2 Onco-hematology Molecular Testing Market Drivers
2.3.3 Onco-hematology Molecular Testing Market Challenges
2.3.4 Onco-hematology Molecular Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Onco-hematology Molecular Testing Players by Revenue
3.1.1 Global Top Onco-hematology Molecular Testing Players by Revenue (2018-2023)
3.1.2 Global Onco-hematology Molecular Testing Revenue Market Share by Players (2018-2023)
3.2 Global Onco-hematology Molecular Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Onco-hematology Molecular Testing Revenue
3.4 Global Onco-hematology Molecular Testing Market Concentration Ratio
3.4.1 Global Onco-hematology Molecular Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Onco-hematology Molecular Testing Revenue in 2022
3.5 Onco-hematology Molecular Testing Key Players Head office and Area Served
3.6 Key Players Onco-hematology Molecular Testing Product Solution and Service
3.7 Date of Enter into Onco-hematology Molecular Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Onco-hematology Molecular Testing Breakdown Data by Type
4.1 Global Onco-hematology Molecular Testing Historic Market Size by Type (2018-2023)
4.2 Global Onco-hematology Molecular Testing Forecasted Market Size by Type (2024-2029)
5 Onco-hematology Molecular Testing Breakdown Data by Application
5.1 Global Onco-hematology Molecular Testing Historic Market Size by Application (2018-2023)
5.2 Global Onco-hematology Molecular Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Onco-hematology Molecular Testing Market Size (2018-2029)
6.2 North America Onco-hematology Molecular Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Onco-hematology Molecular Testing Market Size by Country (2018-2023)
6.4 North America Onco-hematology Molecular Testing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Onco-hematology Molecular Testing Market Size (2018-2029)
7.2 Europe Onco-hematology Molecular Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Onco-hematology Molecular Testing Market Size by Country (2018-2023)
7.4 Europe Onco-hematology Molecular Testing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Onco-hematology Molecular Testing Market Size (2018-2029)
8.2 Asia-Pacific Onco-hematology Molecular Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Onco-hematology Molecular Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Onco-hematology Molecular Testing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Onco-hematology Molecular Testing Market Size (2018-2029)
9.2 Latin America Onco-hematology Molecular Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Onco-hematology Molecular Testing Market Size by Country (2018-2023)
9.4 Latin America Onco-hematology Molecular Testing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Onco-hematology Molecular Testing Market Size (2018-2029)
10.2 Middle East & Africa Onco-hematology Molecular Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Onco-hematology Molecular Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Onco-hematology Molecular Testing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Asusragen, Inc.
11.1.1 Asusragen, Inc. Company Detail
11.1.2 Asusragen, Inc. Business Overview
11.1.3 Asusragen, Inc. Onco-hematology Molecular Testing Introduction
11.1.4 Asusragen, Inc. Revenue in Onco-hematology Molecular Testing Business (2018-2023)
11.1.5 Asusragen, Inc. Recent Development
11.2 Bio-Rad Laboratories,Inc.
11.2.1 Bio-Rad Laboratories,Inc. Company Detail
11.2.2 Bio-Rad Laboratories,Inc. Business Overview
11.2.3 Bio-Rad Laboratories,Inc. Onco-hematology Molecular Testing Introduction
11.2.4 Bio-Rad Laboratories,Inc. Revenue in Onco-hematology Molecular Testing Business (2018-2023)
11.2.5 Bio-Rad Laboratories,Inc. Recent Development
11.3 ICON Plc
11.3.1 ICON Plc Company Detail
11.3.2 ICON Plc Business Overview
11.3.3 ICON Plc Onco-hematology Molecular Testing Introduction
11.3.4 ICON Plc Revenue in Onco-hematology Molecular Testing Business (2018-2023)
11.3.5 ICON Plc Recent Development
11.4 Integrated DNA Technologies, Inc.
11.4.1 Integrated DNA Technologies, Inc. Company Detail
11.4.2 Integrated DNA Technologies, Inc. Business Overview
11.4.3 Integrated DNA Technologies, Inc. Onco-hematology Molecular Testing Introduction
11.4.4 Integrated DNA Technologies, Inc. Revenue in Onco-hematology Molecular Testing Business (2018-2023)
11.4.5 Integrated DNA Technologies, Inc. Recent Development
11.5 Illumina, Inc.
11.5.1 Illumina, Inc. Company Detail
11.5.2 Illumina, Inc. Business Overview
11.5.3 Illumina, Inc. Onco-hematology Molecular Testing Introduction
11.5.4 Illumina, Inc. Revenue in Onco-hematology Molecular Testing Business (2018-2023)
11.5.5 Illumina, Inc. Recent Development
11.6 Invivoscribe, Inc.
11.6.1 Invivoscribe, Inc. Company Detail
11.6.2 Invivoscribe, Inc. Business Overview
11.6.3 Invivoscribe, Inc. Onco-hematology Molecular Testing Introduction
11.6.4 Invivoscribe, Inc. Revenue in Onco-hematology Molecular Testing Business (2018-2023)
11.6.5 Invivoscribe, Inc. Recent Development
11.7 QIAGEN N.V.
11.7.1 QIAGEN N.V. Company Detail
11.7.2 QIAGEN N.V. Business Overview
11.7.3 QIAGEN N.V. Onco-hematology Molecular Testing Introduction
11.7.4 QIAGEN N.V. Revenue in Onco-hematology Molecular Testing Business (2018-2023)
11.7.5 QIAGEN N.V. Recent Development
11.8 Thermo Fisher Scientific, Inc.
11.8.1 Thermo Fisher Scientific, Inc. Company Detail
11.8.2 Thermo Fisher Scientific, Inc. Business Overview
11.8.3 Thermo Fisher Scientific, Inc. Onco-hematology Molecular Testing Introduction
11.8.4 Thermo Fisher Scientific, Inc. Revenue in Onco-hematology Molecular Testing Business (2018-2023)
11.8.5 Thermo Fisher Scientific, Inc. Recent Development
11.9 Cepheid
11.9.1 Cepheid Company Detail
11.9.2 Cepheid Business Overview
11.9.3 Cepheid Onco-hematology Molecular Testing Introduction
11.9.4 Cepheid Revenue in Onco-hematology Molecular Testing Business (2018-2023)
11.9.5 Cepheid Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details